GSIIX
Price
$46.33
Change
-$1.23 (-2.59%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GSIIX vs RMFCX

Header iconGSIIX vs RMFCX Comparison
Open Charts GSIIX vs RMFCXBanner chart's image
Goldman Sachs Equity Income Instl
Price$46.33
Change-$1.23 (-2.59%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GSIIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSIIX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSIIX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GSIIX (410M). GSIIX (1.75) and RMFCX (1.69) have matching dividends . GSIIX was incepted earlier than RMFCX: GSIIX (29 years) vs RMFCX (23 years). GSIIX is a more actively managed with annual turnover of: 32.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GSIIX: RMFCX (250) vs GSIIX (1000000). GSIIX annual gain was more profitable for investors over the last year : 11.80 vs. RMFCX (9.39). RMFCX return over 5 years is better than : 36.51 vs. GSIIX (26.82).
GSIIXRMFCXGSIIX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years23 years-
Gain YTD10.5638.896119%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets410M98.7B0%
Annual Yield % from dividends1.751.69103%
Returns for 1 year11.809.39126%
Returns for 3 years11.6311.57101%
Returns for 5 years26.8236.5173%
Returns for 10 years69.5558.17120%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc